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Abstract 
Complications of diabetes mellitus, namely diabetic retinopathy and diabetic 
maculopathy, are the leading cause of blindness in working aged people.  Sufferers 
can avoid blindness if identified early via retinal imaging.  Systematic screening of 
the diabetic population has been shown to greatly reduce prevalence and incidence 
of blindness within the population.  Many national screening programmes have 
digital fundus photography as their basis.   
In the past five years several techniques and adapters have been developed that 
allow digital fundus photography to be performed using smartphones.  We review 
recent progress in smartphone-based fundus imaging and discuss its potential for 
integration into national systematic DR screening programmes. 
Some systems have produced promising initial results with respect to their 
agreement with reference standards. 
However further multi-ƐŝƚĞƚƌŝĂůůŝŶŐŽĨƐƵĐŚƐǇƐƚĞŵƐ ?ƵƐĞǁŝƚŚŝn implementable 
screening workflows is required if an evidence base strong enough to affect policy 
change is to be established.  If this were to occur national diabetic retinopathy 
screening would, for the first time, become possible in low- and middle-income 
settings where cost and availability of trained eye-care personnel are currently key 
barriers to implementation.  As diabetes prevalence and incidence is increasing 
sharply in these settings, the impact on global blindness could be profound. 
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Introduction 
Diabetic retinopathy (DR) and diabetic maculopathy (DMac) are the leading causes 
of blindness in high-income settings for those aged between 20 and 74 years [1].  As 
the most common microvascular complications of diabetes mellitus (DM), they are 
also increasingly becoming a major cause of blindness in low- and middle-income 
countries (LMICs) as DM prevalence and incidence in these settings has risen sharply 
in recent years [2]. 
Although the development of sight-threatening complications of DM can be delayed 
by appropriate treatment of systemic diseases such as DM itself, high blood pressure 
and lipid metabolism abnormalities [3], nearly all type 1 DM patients and 60% type 2 
patients develop DR or DMac [4].  If the disease progresses to a stage where direct 
intervention is necessary, laser treatment or intravitreal injection of steroid or 
antivascular endothelial growth-factor (anti-VEGF) agents are often successful in 
preserving vision [4].  In each case, early diagnosis is crucial to the success of the 
treatment [5]. 
Diagnosis of DR and DMac is commonly achieved by imaging the fundus either by 
retinal photography, by direct or indirect ophthalmoscopy, or by slit lamp 
biomicroscopy [6].  Given the criticality of early diagnosis, opportunistic diagnosis of 
DR during routine eye examinations is insufficient.  Consequently, many countries 
have adopted systematic screening programmes within their DM populations in 
order to reduce the numbers of people developing blinding disease [7-11] 
Development of the Diabetic Retinopathy Screening Workflow 
In 1980 Iceland became the first country to introduce nationwide, systematic retinal 
screening amongst patients with DM [7].  Approximately 90% of ƚŚĞĐŽƵŶƚƌǇ ?Ɛ
several hundred insulin-treated diabetic patients were examined on an annual or 
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ďŝĞŶŶŝĂůďĂƐŝƐ ?Ăƚ/ĐĞůĂŶĚ ?ƐƐŝŶŐůĞĚŝĂďĞƚĞƐĐůŝŶŝĐ[12].  During each patient visit eye 
and general health histories were first reviewed, followed by visual acuity 
measurements.  An examination of the posterior segment would then be conducted 
by an ophthalmologist specialising in retina with the posterior pole being examined 
by slit lamp biomicroscopy and the peripheral retina being examined by indirect 
ophthalmoscopy.  Colour photographs of the fundus would also be taken during 
each visit.  Macular laser treatment or panretinal photocoagulation would then be 
performed as appropriate [13].  The result of this programme has been the 
reduction of the prevalence of blindness within the diabetic population from 2.4% to 
0.5% [14]. 
In the United Kingdom, every DM patient over the age of twelve is offered an annual 
retinal examination.  As the UK has a diabetic population of close to 2 million people 
[8], a different screening approach to that of the Icelandic model has been adopted.  
During each patient visit a medical history is taken (although this is not used for 
referral decisions), visual acuity is assessed and 45° field digital images of each 
fundus are photographed under dilation [15].  The fundus images are then 
forwarded to a grading centre for grading by an experienced grader holding the 
appropriate vocational qualification [16].  All images graded abnormal and 10% of 
those graded normal are independently graded by a second grader.  Only if the 
graders disagree is the image subsequently forwarded to an ophthalmologist 
specialising in retina.  Patients who are found to have no visible maculopathy and 
either no visible or only background retinopathy are asked to return the following 
year for rescreening whilst unclassifiable patients and those with other grades of 
disease are referred to an eye clinic [15].  In contrast to the Icelandic model, this 
workflow does not require each patient to be examined by an ophthalmologist nor 
does it involve biomicroscopy or indirect ophthalmoscopy during the initial 
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screening stage.  The model therefore more readily lends itself to the deployment of 
non-hospital based clinics, such as mobile clinics or eye screening clinics based 
within primary care centres.  These have been shown to increase screening 
effectiveness in rural and remote settings as well as being a more cost-effective 
means of detecting DR compared to classical techniques [17].  Predominantly as a 
result of nationwide screening, DR is no longer the leading cause of blindness 
amongst working-age adults in the UK, having been so for at least 50 years [18].  
Similar screening workflows have been adopted in several other European nations 
keen to also reduce DR-related blindness [9-11]. 
Additionally, automated screening algorithms have begun to be incorporated into 
the national DR screening programme in Scotland, U.K. [19].  These offer the 
potential to screen out the bulk of healthy, and most time consuming to assess, 
images before a human retinal screener needs to be involved [20].  This requires a 
workflow where digital fundus photography is used during the first stage of 
screening. 
It should be noted that although the majority of diabetes suffers live in LMICs, 
where nationwide DR screening and care has thus far not been effectively 
implemented, with only rudimentary detection and management existing in many 
countries [21].  Barriers to effective DR care implementation include: few 
ophthalmologists trained in DR management, lack of fundoscopy training for eye 
health workers including opticians and ophthalmic clinical officers, poorly 
functioning referral systems from primary to secondary care, little access to imaging 
technology, lack of treatment infrastructure such as properly maintained lasers, and 
a lack of relevant national policies [21]. 
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Diabetic Retinopathy Screening Requirements for Digital 
Photography 
The advancement of DR grading using digital fundus images has been reviewed in 
detail elsewhere [22].  Modern digital camera sensors have exceeded the resolution 
of traditional 35-mm film [23] and digital fundus cameras have superseded their film 
predecessors.  However, the quality of the image formed on the detector is also 
affected by aberrations within the camera optics, distortion, field curvature and is 
ultimately limited by diffraction.  It is such factors that limit the image quality of 
modern digital cameras rather than the sensor resolution (pixel count  ? 
 ?megapixels ?), which is nevertheless frequently provided as a sole measure of digital 
camera quality by manufacturers and in some peer-reviewed literature.  Appropriate 
assessment of a fundus camera ?Ɛ optical quality is achieved by using a specially 
designed test target (USAF 1951 resolution test chart, shown in Figure 1) to 
determine its resolving power, measured in line pairs per mm (lp/mm).  This involves 
finding the minimum resolvable separation of a set of three parallel black lines, with 
a width equal to their separation, on a white background [24].  The current 
international standard for fundus cameras specifies a lower limit of 80 lp/mm in the 
image centre to 40 lp/mm at the periphery for a field-of-view (FoV) of 30° or less 
and 60 lp/mm to 25 lp/mm for a FoV greater than 30° [25]. 
dŚĞĐŽŶƚŝŶƵĞĚŝŶĐƌĞĂƐĞŝŶƚŚĞƋƵĂůŝƚǇŽĨƐŵĂƌƚƉŚŽŶĞƐ ?ĞŵďĞĚĚĞĚĐĂŵĞƌĂƐŝƐ
therefore of interest, with recent handsets capturing images with quality 
ĐŽŵƉĂƌĂďůĞƚŽƚŚŽƐĞŽĨĐŽŵƉĂĐƚĚŝŐŝƚĂůĐĂŵĞƌĂƐ ?dŽĚĂǇ ?ƐŚĂŶĚƐĞƚƐĐĂŶĂůƐŽƌĞĐŽƌĚ
high-quality videos at 1080p (1920 x 1080 pixels per frame) high-definition 
resolution, and even 4K (4096 x 2160 pixels per frame) ultra-high-definition 
resolution, in the case of some high-end devices. 
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However, as noted above, image quality relies on a host of parameters besides 
sensor pixel count.  The engineering challenges in building quality camera optics 
within a mobile phone are substantial.  The requirement to be low-cost and capture 
a wide variety of scenes necessitates plastic lenses suitable for mass production and 
an aperture with a fixed diameter.  Also the whole camera module needs to be thin, 
limiting the allowed space between optical components.  Finally, as with any digital 
camera, how the image is encoded and compressed after acquisition can also 
degrade the image quality. 
Nevertheless, in recent years the advancement of smartphone imaging technology 
has been such that fundoscopy systems have begun to emerge using smartphone 
cameras as the imaging component.   
Smartphone Prevalence 
The introduction of smartphones has had a profound impact on mobile connectivity, 
combining the simple voice and text communication capabilities of their 
predecessors with more powerful computer processing, an operating system 
allowing application installation and upgrade, global positioning systems, high-
resolution cameras, and a variety of other sensors such as accelerometers and 
fingerprint scanners [26].  Such is the appeal of this technologically-rich resource 
that in 2013 it was reported that 65% of US adults owned a smartphone [27].  
Medical professionals are certainly no exception with it being reported as early as 
2010 that 80% of medical doctors in the UK owned a smartphone [28].  
Furthermore, the phenomenon is not confined to high-income settings.  For 
example it was reported in 2014 that in China there is 95% mobile phone ownership 
and 37% smartphone ownership whilst in Kenya 82% own mobile phones with 1 in 4 
of these being a smartphone [29]. 
Page 9 of 23 
 
Using such a universally available consumer device as the basis of fundus imaging 
systems may offer a means of removing many of the aforementioned barriers to 
timely detection and treatment of DR where nationwide screening does not 
currently exist and significantly lower costs where it does.  For this to be realised, 
the technology must be of sufficient quality and also be capable of integration into 
the DR workflow.  In this paper we review recent progress in smartphone-based 
fundus imaging and discuss its potential for integration into national systematic DR 
screening programmes. 
Review of Smartphone Retinal Imaging Technology 
Smartphone Slit Lamp Adapters 
The simplest means of introducing the imaging capabilities of smartphones into 
ƌĞƚŝŶĂůŝŵĂŐŝŶŐǁŽƌŬĨůŽǁƐŝƐƚŽƐŝŵƉůǇ ?ďŽůƚ-ŽŶ ?ŚĂŶĚƐĞƚƐƚŽĞǆŝƐƚŝŶŐƌĞƚŝŶĂůŝŵĂŐŝŶŐ
equipment.  Barsam et al. have shown that it is possible to capture good quality 
anterior segment images by manually aligning the optic of a smartphone (iPhone 3G, 
Apple Inc., Cupertino, CA, USA) with either eyepiece of a biomicroscope slit lamp 
(BM 900, Haag-Streit, Köniz, Switzerland) [30].  Although the authors only reported 
anterior segment images, it was later shown by Gurram et al. that it is possible to 
capture retinal images by inserting a 90D condensing ůĞŶƐďĞƚǁĞĞŶƚŚĞƉĂƚŝĞŶƚ ?ƐĞǇĞ
and the biomicroscope and aligning the light source with the optical axis [31]. 
Monocular Indirect Ophthalmoscopy 
In 2010 Lord et al. reported a simple method for capturing retinal images similar to 
classical indirect ophthalmoscopy [32].  This involved holding a 20D lens in-front of 
the patient ?ƐĞǇĞĂŶĚŚŽůĚŝŶŐĂƉĞŶƚŽƌĐŚĂŶĚƐŵĂƌƚƉŚŽŶĞ ?ŝWŚŽŶĞ ?ƉƉůĞ/ŶĐ.) at a 
distance using the other hand.  They found that the smartphone camera would then 
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autofocus onto the retinal image formed by the lens allowing a digital image to be 
ĐĂƉƚƵƌĞĚƵƐŝŶŐƚŚĞƉŚŽŶĞ ?ƐƐƚŽĐŬĐĂŵĞƌĂĂƉƉůŝĐĂƚŝŽŶ ?ƐƐŵĂƌƚƉŚŽŶĞƚĞĐŚŶŽůŽŐǇ
matured and integrated LED flashes became commonplace, the smartphone could 
itself deliver the necessary co-axial retinal illumination, dispensing with the need to 
balance a torch alongside the phone, ĂƚĞĐŚŶŝƋƵĞĐŽŝŶĞĚ ?ƐŵĂƌƚƉŚŽŶĞĨƵŶĚŽƐĐŽƉǇ ? 
and shown in Figure 2 [33].  Although this reduced the complexity of the procedure, 
finding and holding the lens at the correct distance from the eye nevertheless 
requires a level of skill generally only exhibited by ophthalmologists or trained eye-
care personnel.   
Ryan et al. compared using this technique with an iPhone 5 (Apple Inc.) to standard 
three-field non-mydriatic and seven-field mydriatic retinal photography on 300 
pharmacologically dilated diabetic patients [34].  The authors found the sensitivity of 
the smartphone images to be 81% and 50% compared to each standard respectively 
and the specificity to be 94% against each standard.  They therefore concluded that 
20D lens-assisted smartphone photography lacks sufficient sensitivity for detection 
of DR. 
Myung et al. used 3d printing technology to simplify the above procedure.  The 
authors designed the plastic arm shown in Figure 3 which holds the lens at a fixed 
distance from the camera, allowing the entire system to be held and moved as a 
single unit [35].  Hong et al. reported a similar, publically available design allowing 
anyone with access to a 3d printer to build the system [36].  However the distance 
between the lens and the eye is not fixed and therefore a degree of skill is still 
required to form the retinal image.   
Ophthalmoscope manufacturer Welch Allyn Inc. (Skaneateles Falls, NY, USA) has 
released a commercially available means of acquiring smartphone images.  The 
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iExaminer adapter for the PanOptic allows retinal images with a 25° subtended angle 
to be captured using an iPhone 4 or 4S (Apple Inc.) whilst keeping all optical 
dimensions fixed [37].  Although this is the only such device to achieve U.S. Food and 
Drug Administration approval to-date, the system, excluding smartphone, retails at 
over 1000 USD and has not been updated for current handset models, meaning it is 
now out-of-date with respect to phone models actively on the market [38]. 
Direct Ophthalmoscopy 
Two adapters that allow smartphones to capture retinal images through direct 
ŽƉŚƚŚĂůŵŽƐĐŽƉǇŚĂǀĞƐŝŶĐĞďĞĞŶƚŚĞĚĞǀĞůŽƉĞĚ ? ‘WĞĞŬZĞƚŝŶĂ ?ƵƐĞƐĂƉƌŝƐŵƚŽ
closely align a light source with the optical axis of the smartphone camera [39] and 
 ‘-ǇĞ ? ?-Eye Srl, Padova, Italy) inserts a beam-splitter into the optical path of the 
camera optics to provide co-axial illumination of the eye using the LED flash [40].   
The inventor of D-Eye, shown in Figure 4, and colleagues have reported results from 
the examination of 240 eyes in 120 out-patients with either type I or type II DM at 
an ophthalmic diabetic centre (Spedali Civili di Brescia, Italy) [41].  They reported a 
sensitivity of 0.90 (95% CI 0.82-0.94) and a specificity of 0.96 (95% CI 0.90-0.98) for 
detection of DR by a retinal specialist when compared to biomicroscopy by a retinal 
specialist.  For grading of DR a ƐŝŵƉůĞʃ of 0.78 (95% CI 0.71-0.84; p < 0.001) was 
reported and 3.75% of eyes were ungradable with D-Eye compared to 1.7% with 
biomicroscopy.  With respect to detecting significant cystoid macular edema a 
sensitivity of 0.81 (95% CI 0.57-0.94), a specificity of 0.98 (95% CI 0.95-0.99) and a 
simple ʃ of 0.79 (95% CI 0.65-0.93) were reported when compared to 
biomicroscopy.  In each case examinations and assessments were made by retinal 
specialists only. 
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dŽƚŚĞĂƵƚŚŽƌƐ ?ŬŶŽǁůĞĚŐĞ ?ƚŚĞƌĞŝƐƉƌĞƐĞŶƚůǇŶŽƉĞĞƌ-reviewed comparison of D-
Eye to conventional digital fundus photography, the gold standard and the only 
means used for the detection in the first stage of many national screening 
programmes.   
Peek Retina has been used in validation studies in LMICs ?dŚĞĚĞǀŝĐĞ ?ƐƉĞƌĨŽƌŵĂŶĐĞ
was first compared to a DRS retinal camera (Haag-Streit) nested within a population-
based cohort study of eye disease in Nakuru, Kenya [42].  Fundus images of both 
eyes were taken for 1,328 participants by non-healthcare trained, lay examiners 
using Peek Retina and by a specialist technician using the retinal camera.  These 
images were then sent to Moorfields Eye Hospital Reading Centre (London, U.K.) for 
independent grading.  The authors reported a weighted kappa of 0.71 when 
comparing lay examiners using Peek Retina with an ophthalmic technician using the 
reference desktop camera for optic nerve examination.  Bland-Altman analysis 
demonstrated an average difference of -0.02 with 95% limits of agreement between 
-0.21 and 0.16 for vertical cup-to-disc ratio assessment, suggesting good agreement 
between the lay-operated Peek Retina and the reference standard [43]. 
Peek Retina pre-production prototypes, shown in Figure 5, are presently being 
trialled alongside standard digital (Topcon NRW6, Topcon Corp., Tokyo, Japan) 
cameras in an 18-site DR screening implementation and evaluation in Moshi, 
Tanzania.  Although this study is still in progress, interim data has indicated good 
agreement between DR grading of images acquired by general clinical staff with a 
conventional fundus camera and Peek Retina when both are performed under 
dilation (Mwanansao C, et al., unpublished manuscript). 
Given that systematic DR screening in Sub-Saharan Africa is presently rarely 
available, the prospect of implementing an effective programme in a highly 
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challenging environment such as the Kilimanjaro region is most exciting.  If the full 
results are to replicate those initially being indicated, then this will lend strong 
supporting evidence for the effectiveness of smartphone-based systematic DR 
screening. 
Discussion 
Despite their immense potential, thus far a very low proportion of the relatively 
numerous mHealth technology pilot studies conducted have gone on to achieve full 
integration into healthcare systems [44].  A variety of reasons for this have been 
noted including failure to keep pace with the rapidly developing mobile phone 
sector, failure to recognise design decisions which affect the workflow and the need 
for better coordination between technologists, clinicians and policy makers in 
developing the common standards and frameworks necessary [45-47]. 
In these respects smartphone retinal imaging technology is no exception.   
With regards to keeping pace with the broader mobile phone market, a functioning 
screening programme will inevitably require replacement devices during its life.  If 
the technology in use is only compatible with obsolete, and no longer manufactured, 
handsets then the programme will begin to break down as handsets age and require 
replacing.  Ideally the device would therefore be independent of its host handset.  
Nevertheless, constant attention will have to be paid by smartphone imaging 
ĂĚĂƉƚĞƌŵĂŶƵĨĂĐƚƵƌĞƌƐƚŽĞŶƐƵƌĞƚŚĂƚƚŚĞŝƌĂƚƚĂĐŚŵĞŶƚƐ ?ƋƵĂůŝƚǇ ?ĞĂƐĞ-of-use or 
even safety are not degraded by developments and trends within the mobile phone 
sector, or risk becoming obsolete in as little as two to three years after product 
launch. 
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The existing published literature relating to smartphone-based DR screening has 
ƚŚƵƐĨĂƌŵŽƐƚůǇĐŽŶƐŝƐƚĞĚŽĨŽƉŚƚŚĂůŵŽůŽŐŝƐƚƐ ?ƐŝŶŐůĞ-site comparisons to reference 
standards.  This is a vital first step in validating the clinical usefulness of the 
technology and we commend the robust comparison of smartphone indirect 
ophthalmoscopy to standard retinal photography by Ryan et al. [34] in particular.  
However unless the technology can be effectively integrated into the appropriate 
clinical workflows, where there are non-clinical operators and graders, it cannot be 
adopted.  Additionally new ways of structuring clinical workflows around the 
technologies have been postulated but there is little peer-reviewed literature 
showing the impact of these new workflows on patient outcomes.  Thus, at present, 
policy makers are lacking the evidence they need to implement national screening 
programmes based around mHealth.   
To this end, the on-going multi-site trial of Peek Retina and a referral system in 
Tanzania and its planned expansion to other similar studies in other countries are 
critically important in establishing the evidence base necessary for smartphone-
based systematic DR screening.  Developers of smartphone retinal imaging 
technologies should investigate the effectiveness of these tools within 
implementable DR screening workflows, with the rigour and scale appropriate for 
the trialling of any such medical device. 
Conclusions 
Pilot studies and single-site trials have produced promising results for the validation 
of smartphone-based DR assessment versus reference standards.  However, by 
nature, the implementation of national, systematic screening programmes is top-
down.  Continued collaboration across medicine, engineering, healthcare policy and 
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other disciplines in adapting to local standards and filling gaps in the current 
literature is required in order to shape national DR strategies.  Specifically, more 
literature describing multi-site trialling, the impact of the technology on the whole 
clinical workflow, and ultimately the impact on the health outcomes of the screened 
population are required in order to shape national DR strategies. 
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Figures and Figure Legends 
 
Figure 1 - USAF 1951 resolution test chart (not to scale).  The resolving power of an 
optical imaging system is found according to the group and element of the smallest 
three line patern that can be resolved, according to the equation: ݎ݁ݏ݋݈ݑݐ݅݋݊ ൌʹ௚௥௢௨௣ାሺ௘௟௘௠௘௡௧ିଵሻ ଺Τ .  For example the bottom-left target corresponds to 0.445 
lp/mm and the top-right target corresponds to 0.500 lp/mm.  Reproduced with 
permission from [48]. 
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Figure 2 - Imaging the fundus can be achieved by positioning a 20D lens between the 
eye and the smartphone optic (left and centre).  Although diabetic macular edema, 
for example, can imaged using this technique (right), it has been reported that 
insufficient sensitivity is achieved when the technique is integrated into the 
screening workflow [34].  Left and centre panel reproduced with permission from 
[33], right panel reproduced with permission from [34]. 
 
 
 
Figure 3  ?The 3d printed smartphone retinal adapter for monocular indirect 
ophthalmoscopy developed by Myung et al. [35] on an iPhone 5 (Apple Inc.) (left).  
Diabetic macular edema can be photographed using this lens-to-phone mount 
(right).  Reproduce with permission from [35]. 
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Figure 4  ? Example mydriatic retinal images taken with the  ‘D-Eye ? on iPhone 6 (far 
left).  Mild nonproliferative diabetic retinopathy (second from left), moderate 
nonproliferative diabetic retinopathy (second from right) and panretinal 
photocoagulation scars on a retina with proliferative diabetic retinopathy (far right).  
Reproduced with permission from [41]. 
 
 
 
Figure 5  ? The pre-production prototype of  ‘Peek Retina ? on a Samsung S3 (left) uses 
a prism to project a light beam which is closely aligned to camera optical axis.  It is 
currently being trialled alongside reference standards in a diabetic retinopathy study 
in Moshi, Tanzania (frame of captured video, right). 
